Intravenous Immune Globulin Therapies Market Report

Global and Region Intravenous Immune Globulin Therapies Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：212
  • REPORT CODE：GMM1008035
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Intravenous Immune Globulin Therapies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Intravenous Immune Globulin Therapiesmarket, defines the market attractiveness level of Intravenous Immune Globulin Therapies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Intravenous Immune Globulin Therapies industry, describes the types of Intravenous Immune Globulin Therapies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Intravenous Immune Globulin Therapies market and the development prospects and opportunities of Intravenous Immune Globulin Therapies industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Intravenous Immune Globulin Therapies market in Chapter 13.

    By Player:

    • Biotest

    • China Biologic Products Holdings

    • Baxter

    • Kamada

    • Hualan Biological Engineering

    • Kedrion

    • Sichuan Yuanda Shuyang Pharmaceutical

    • CSL Plasma

    • Octapharma

    • Grifols

    By Type:

    • Liquid Form

    • Lyophilized Powder Form

    By End-User:

    • Immunodeficiency

    • Autoimmune Disease

    • Acute Infection

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Intravenous Immune Globulin Therapies Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Intravenous Immune Globulin Therapies Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Intravenous Immune Globulin Therapies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Intravenous Immune Globulin Therapies Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Intravenous Immune Globulin Therapies Market Analysis and Outlook to 2022

    • 7.1 Global Intravenous Immune Globulin Therapies Consumption (2017-2022)

    • 7.2 United States Intravenous Immune Globulin Therapies Consumption (2017-2022)

    • 7.3 Europe Intravenous Immune Globulin Therapies Consumption (2017-2022)

    • 7.4 China Intravenous Immune Globulin Therapies Consumption (2017-2022)

    • 7.5 Japan Intravenous Immune Globulin Therapies Consumption (2017-2022)

    • 7.6 India Intravenous Immune Globulin Therapies Consumption (2017-2022)

    • 7.7 South Korea Intravenous Immune Globulin Therapies Consumption (2017-2022)

    8 Region and Country-wise Intravenous Immune Globulin Therapies Market Analysis and Outlook to 2028

    • 8.1 Global Intravenous Immune Globulin Therapies Consumption Forecast (2022-2028)

    • 8.2 United States Intravenous Immune Globulin Therapies Consumption Forecast (2022-2028)

    • 8.3 Europe Intravenous Immune Globulin Therapies Consumption Forecast (2022-2028)

    • 8.4 China Intravenous Immune Globulin Therapies Consumption Forecast (2022-2028)

    • 8.5 Japan Intravenous Immune Globulin Therapies Consumption Forecast (2022-2028)

    • 8.6 India Intravenous Immune Globulin Therapies Consumption Forecast (2022-2028)

    • 8.7 South Korea Intravenous Immune Globulin Therapies Consumption Forecast (2022-2028)

    9 Global Intravenous Immune Globulin Therapies Market Outlook by Types and Applications to 2022

    • 9.1 Global Intravenous Immune Globulin Therapies Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Liquid Form Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lyophilized Powder Form Consumption and Growth Rate (2017-2022)

    • 9.2 Global Intravenous Immune Globulin Therapies Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Immunodeficiency Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Autoimmune Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Acute Infection Consumption and Growth Rate (2017-2022)

    10 Global Intravenous Immune Globulin Therapies Market Outlook by Types and Applications to 2028

    • 10.1 Global Intravenous Immune Globulin Therapies Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Liquid Form Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Lyophilized Powder Form Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Intravenous Immune Globulin Therapies Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Autoimmune Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Acute Infection Consumption Forecast and Growth Rate (2022-2028)

    11 Global Intravenous Immune Globulin Therapies Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Intravenous Immune Globulin Therapies Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Intravenous Immune Globulin Therapies Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Intravenous Immune Globulin Therapies Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Intravenous Immune Globulin Therapies Market Competitive Analysis

    • 14.1 Biotest

      • 14.1.1 Biotest Company Details

      • 14.1.2 Biotest Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Biotest Intravenous Immune Globulin Therapies Product and Service

    • 14.2 China Biologic Products Holdings

      • 14.2.1 China Biologic Products Holdings Company Details

      • 14.2.2 China Biologic Products Holdings Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Product and Service

    • 14.3 Baxter

      • 14.3.1 Baxter Company Details

      • 14.3.2 Baxter Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Baxter Intravenous Immune Globulin Therapies Product and Service

    • 14.4 Kamada

      • 14.4.1 Kamada Company Details

      • 14.4.2 Kamada Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Kamada Intravenous Immune Globulin Therapies Product and Service

    • 14.5 Hualan Biological Engineering

      • 14.5.1 Hualan Biological Engineering Company Details

      • 14.5.2 Hualan Biological Engineering Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Product and Service

    • 14.6 Kedrion

      • 14.6.1 Kedrion Company Details

      • 14.6.2 Kedrion Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Kedrion Intravenous Immune Globulin Therapies Product and Service

    • 14.7 Sichuan Yuanda Shuyang Pharmaceutical

      • 14.7.1 Sichuan Yuanda Shuyang Pharmaceutical Company Details

      • 14.7.2 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Product and Service

    • 14.8 CSL Plasma

      • 14.8.1 CSL Plasma Company Details

      • 14.8.2 CSL Plasma Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 CSL Plasma Intravenous Immune Globulin Therapies Product and Service

    • 14.9 Octapharma

      • 14.9.1 Octapharma Company Details

      • 14.9.2 Octapharma Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Octapharma Intravenous Immune Globulin Therapies Product and Service

    • 14.10 Grifols

      • 14.10.1 Grifols Company Details

      • 14.10.2 Grifols Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Grifols Intravenous Immune Globulin Therapies Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Intravenous Immune Globulin Therapies

    • Figure Intravenous Immune Globulin Therapies Picture

    • Table Global Intravenous Immune Globulin Therapies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Intravenous Immune Globulin Therapies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Intravenous Immune Globulin Therapies Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Intravenous Immune Globulin Therapies Consumption by Country (2017-2022)

    • Figure United States Intravenous Immune Globulin Therapies Consumption and Growth Rate (2017-2022)

    • Table Europe Intravenous Immune Globulin Therapies Consumption and Growth Rate (2017-2022)

    • Figure China Intravenous Immune Globulin Therapies Consumption and Growth Rate (2017-2022)

    • Figure Japan Intravenous Immune Globulin Therapies Consumption and Growth Rate (2017-2022)

    • Figure India Intravenous Immune Globulin Therapies Consumption and Growth Rate (2017-2022)

    • Figure South Korea Intravenous Immune Globulin Therapies Consumption and Growth Rate (2017-2022)

    • Figure Global Intravenous Immune Globulin Therapies Consumption Forecast by Country (2022-2028)

    • Figure United States Intravenous Immune Globulin Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Intravenous Immune Globulin Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Intravenous Immune Globulin Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Intravenous Immune Globulin Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Intravenous Immune Globulin Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Intravenous Immune Globulin Therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liquid Form Consumption and Growth Rate (2017-2022)

    • Figure Global Lyophilized Powder Form Consumption and Growth Rate (2017-2022)

    • Figure Global Immunodeficiency Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Acute Infection Consumption and Growth Rate (2017-2022)

    • Figure Global Liquid Form Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lyophilized Powder Form Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acute Infection Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Intravenous Immune Globulin Therapies Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Intravenous Immune Globulin Therapies Export by Region (Top 5 Countries) (2017-2028)

    • Table Biotest (Foundation Year, Company Profile and etc.)

    • Table Biotest Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biotest Intravenous Immune Globulin Therapies Product and Service

    • Table China Biologic Products Holdings (Foundation Year, Company Profile and etc.)

    • Table China Biologic Products Holdings Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Biologic Products Holdings Intravenous Immune Globulin Therapies Product and Service

    • Table Baxter (Foundation Year, Company Profile and etc.)

    • Table Baxter Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Intravenous Immune Globulin Therapies Product and Service

    • Table Kamada (Foundation Year, Company Profile and etc.)

    • Table Kamada Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kamada Intravenous Immune Globulin Therapies Product and Service

    • Table Hualan Biological Engineering (Foundation Year, Company Profile and etc.)

    • Table Hualan Biological Engineering Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hualan Biological Engineering Intravenous Immune Globulin Therapies Product and Service

    • Table Kedrion (Foundation Year, Company Profile and etc.)

    • Table Kedrion Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kedrion Intravenous Immune Globulin Therapies Product and Service

    • Table Sichuan Yuanda Shuyang Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Product and Service

    • Table CSL Plasma (Foundation Year, Company Profile and etc.)

    • Table CSL Plasma Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Plasma Intravenous Immune Globulin Therapies Product and Service

    • Table Octapharma (Foundation Year, Company Profile and etc.)

    • Table Octapharma Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Octapharma Intravenous Immune Globulin Therapies Product and Service

    • Table Grifols (Foundation Year, Company Profile and etc.)

    • Table Grifols Intravenous Immune Globulin Therapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grifols Intravenous Immune Globulin Therapies Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US